JMFC
IBB icon

J.M. Forbes & Co’s iShares Biotechnology ETF IBB Stock Holding History

J.M. Forbes & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.25M Sell
43,371
-316
-0.7% -$54.3K 0.65% 49
2026
Q1 		$7.38M Sell
43,687
-13
-0% -$2.22K 0.62% 49
2025
Q4 		$7.38M Buy
43,700
+483
+1% +$78.4K 0.6% 51
2025
Q3 		$6.24M Buy
43,217
+486
+1% +$66.3K 0.52% 56
2025
Q2 		$5.41M Sell
42,731
-256
-0.6% -$31.4K 0.49% 56
2025
Q1 		$5.5M Buy
42,987
+1,725
+4% +$234K 0.53% 55
2024
Q4 		$5.46M Buy
41,262
+352
+0.9% +$49.5K 0.53% 56
2024
Q3 		$5.96M Sell
40,910
-477
-1% -$69K 0.58% 52
2024
Q2 		$5.68M Buy
41,387
+784
+2% +$105K 0.58% 51
2024
Q1 		$5.57M Sell
40,603
-956
-2% -$131K 0.6% 50
2023
Q4 		$5.65M Buy
41,559
+697
+2% +$85K 0.66% 50
2023
Q3 		$5M Buy
40,862
+255
+0.6% +$32.4K 0.65% 51
2023
Q2 		$5.16M Sell
40,607
-19,005
-32% -$2.47M 0.64% 50
2023
Q1 		$7.7M Buy
59,612
+907
+2% +$119K 1.05% 39
2022
Q4 		$7.71M Sell
58,705
-209
-0.4% -$27K 1.11% 37
2022
Q3 		$6.89M Buy
58,914
+815
+1% +$101K 1.08% 37
2022
Q2 		$6.83M Sell
58,099
-28
-0% -$3.32K 1.01% 39
2022
Q1 		$7.57M Sell
58,127
-308
-0.5% -$40.1K 0.96% 43
2021
Q4 		$8.92M Buy
58,435
+148
+0.3% +$22.9K 1.02% 40
2021
Q3 		$9.42M Buy
58,287
+841
+1% +$142K 1.19% 38
2021
Q2 		$9.4M Sell
57,446
-73
-0.1% -$11.2K 1.19% 38
2021
Q1 		$8.66M Buy
57,519
+1,183
+2% +$188K 1.21% 35
2020
Q4 		$8.53M Buy
56,336
+214
+0.4% +$30.6K 1.25% 33
2020
Q3 		$7.6M Sell
56,122
-81
-0.1% -$11K 1.22% 33
2020
Q2 		$7.68M Buy
56,203
+97
+0.2% +$12.4K 1.37% 32
2020
Q1 		$6.04M Buy
56,106
+3,036
+6% +$350K 1.35% 32
2019
Q4 		$6.39M Buy
53,070
+3,782
+8% +$422K 1.05% 43
2019
Q3 		$4.9M Buy
49,288
+295
+0.6% +$30.9K 0.94% 43
2019
Q2 		$5.34M Buy
48,993
+5,298
+12% +$564K 1.03% 41
2019
Q1 		$4.88M Buy
43,695
+564
+1% +$61.9K 1.05% 41
2018
Q4 		$4.16M Sell
43,131
-194
-0.4% -$20.6K 0.98% 42
2018
Q3 		$5.28M Buy
43,325
+73
+0.2% +$8.6K 1.12% 41
2018
Q2 		$4.75M Buy
43,252
+62
+0.1% +$6.63K 1.06% 41
2018
Q1 		$4.61M Buy
43,190
+452
+1% +$50.1K 1.07% 41
2017
Q4 		$4.56M Buy
42,738
+1,023
+2% +$109K 1.05% 42
2017
Q3 		$4.64M Sell
41,715
-570
-1% -$60.9K 1.16% 37
2017
Q2 		$4.37M Sell
42,285
-210
-0.5% -$20.7K 1.11% 37
2017
Q1 		$4.15M Sell
42,495
-231
-0.5% -$22.1K 1.08% 38
2016
Q4 		$3.78M Buy
42,726
+219
+0.5% +$19.9K 1.04% 39
2016
Q3 		$4.1M Sell
42,507
-756
-2% -$71.9K 1.12% 39
2016
Q2 		$3.71M Buy
43,263
+768
+2% +$68.9K 1.03% 40
2016
Q1 		$3.69M Buy
42,495
+1,041
+3% +$93.1K 1.05% 38
2015
Q4 		$4.67M Sell
41,454
-156
-0.4% -$16.9K 1.25% 39
2015
Q3 		$4.21M Buy
41,610
+90
+0.2% +$10.8K 1.2% 39
2015
Q2 		$5.11M Sell
41,520
-894
-2% -$107K 1.37% 36
2015
Q1 		$4.86M Sell
42,414
-411
-1% -$45.3K 1.29% 37
2014
Q4 		$4.54M Buy
42,825
+513
+1% +$49.9K 1.19% 38
2014
Q3 		$3.86M Sell
42,312
-288
-0.7% -$25.3K 0.98% 44
2014
Q2 		$3.65M Buy
42,600
+33
+0.1% +$2.6K 0.91% 43
2014
Q1 		$3.35M Sell
42,567
-333
-0.8% -$27.7K 0.87% 44
2013
Q4 		$3.25M Buy
42,900
+546
+1% +$38.7K 0.82% 48
2013
Q3 		$2.96M Buy
+42,354
New +$2.77M 0.84% 48

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

J.M. Forbes & Co's IBB Position: Q2 2026 in Review

J.M. Forbes & Co reduced its iShares Biotechnology ETF (IBB) stake by 0.72% in Q2 2026, selling an estimated $54.3K and leaving 43,371 shares worth $8.25M. The position accounts for 0.65% of the portfolio, ranked #49.

J.M. Forbes & Co first reported a position in IBB in Q3 2013 and has held it in 52 quarters since. The position peaked at $9.42M in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • J.M. Forbes & Co held 43,371 shares of iShares Biotechnology ETF worth $8.25M as of Q2 2026.
  • J.M. Forbes & Co sold 316 iShares Biotechnology ETF shares in Q2 2026, an estimated $54.3K.
  • iShares Biotechnology ETF made up 0.65% of J.M. Forbes & Co's portfolio in Q2 2026, its #49 holding.
  • J.M. Forbes & Co first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 52 quarters since.
  • J.M. Forbes & Co's iShares Biotechnology ETF position peaked at $9.42M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on J.M. Forbes & Co's 13F filing for Q2 2026, filed 20 Jul 2026.